iRadimed
IRMD
37 hedge funds and large institutions have $26.3M invested in iRadimed in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
87% more capital invested
Capital invested by funds: $14M → $26.3M (+$12.2M)
43% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 7
28% more funds holding
Funds holding: 29 → 37 (+8)
2.61% more ownership
Funds ownership: 13.79% → 16.4% (+2.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Boston Partners
Boston,
Massachusetts
|
+$563K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$445K |
| 3 |
Renaissance Technologies
New York
|
+$405K |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$383K |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
+$268K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$394K |
| 2 |
Morgan Stanley
New York
|
-$204K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$174K |
| 4 |
SIM
Spark Investment Management
New York
|
-$147K |
| 5 |
MC
Menta Capital
San Francisco,
California
|
-$41.9K |
IRMD Hedge Fund Activity: Q4 2017 in Review
37 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q4 2017, worth a combined $26.3M — up 87% from $14M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new IRMD positions and 2 closed out — a net gain of 8 holders — while 10 added to existing stakes and 7 trimmed.
The largest buyer was Boston Partners, opening a new position worth an estimated $563K. The largest seller was AQR Capital Management, cutting an estimated $394K.
- 37 institutional investors held iRadimed (IRMD) as of Q4 2017, up from 29 in Q3 2017.
- Funds reported $26.3M of iRadimed stock for Q4 2017, up 87% quarter-over-quarter.
- 10 funds opened new iRadimed positions in Q4 2017 and 2 closed out, a net change of +8 holders.
- The largest iRadimed buyer in Q4 2017 was Boston Partners, an estimated $563K added.
- The largest iRadimed seller in Q4 2017 was AQR Capital Management, an estimated $394K sold.
Based on aggregated 13F filings for Q4 2017.